Latest Tax Credits News

Insurance Australia Group Limited has announced a fully franked interim dividend of AUD 0.12 per share for the half-year ending December 2025, alongside a dividend reinvestment plan with no discount.

Evolution Mining Limited has announced a fully franked ordinary dividend of AUD 0.20 per share for the half-year ending December 2025, accompanied by a Dividend Reinvestment Plan with no discount.

AGL Energy Limited has announced a fully franked ordinary dividend of AUD 0.24 per share for the six months ending December 2025, payable in March 2026. This dividend reflects the company’s steady financial footing amid ongoing market challenges.

SGH Limited has announced a fully franked ordinary dividend of AUD 0.32 per share for the six months ending December 2025, signalling steady returns for shareholders.

Future Generation Global Limited has announced a fully franked special dividend of AUD 0.03 per share for the half-year ending December 2025, accompanied by a dividend reinvestment plan with no discount.

Apiam Animal Health Limited has announced a special fully franked dividend of AUD 0.10 per share, with payment scheduled for mid-February 2026. Notably, the company has suspended its dividend reinvestment plan for this payout.

Pinnacle Investment Management Group Limited has announced a fully franked ordinary dividend of AUD 0.29 per share for the half-year ending December 2025, with a dividend reinvestment plan available to shareholders.

Apiam Animal Health shareholders have predominantly elected to receive scrip or mixed consideration in the proposed acquisition, with a special dividend of 10 cents per share proposed pending scheme approval.

Renegade Exploration has reported significant progress across its North American and Australian mineral portfolios, highlighting high-grade gold, silver, and critical mineral results and planning a maiden drill program at its Yukon Myschka Project in 2026.

Cann Group Limited has reported its first-ever free cash flow positive quarter, following a significant debt restructuring and a $9 million capital raise. Despite a softer quarterly revenue, the company is advancing new product launches and export partnerships, positioning itself for growth.

Carnegie Clean Energy has made significant strides in its wave energy technology, progressing the ACHIEVE Programme and launching a €4 million EU-funded project to reduce costs, while securing a prestigious Defence innovation award.

Neurotech International has secured a Rare Pediatric Disease Designation from the FDA for its lead drug NTI164 targeting Rett syndrome, alongside publishing promising clinical data and raising $8.7 million to fuel further development.